GT Biopharma, Inc. (GTBP)
NASDAQ · Healthcare
GT Biopharma, Inc. Total Assets 2010–2020
GT Biopharma, Inc. annual total assets history from 2010 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
- GT Biopharma, Inc. total assets as of December 31, 2020: 5.7M, a 1329.55% increase year-over-year.
- GT Biopharma, Inc. total assets for 2020 were 5.7M, a 1329.55% increase from 2019.
- GT Biopharma, Inc. total assets for 2019 were 396,000, a 99.84% decrease from 2017.
- GT Biopharma, Inc. total assets for 2017 were 254.4M, a 1017372.00% increase from 2016.
- GT Biopharma, Inc. total assets for 2016 were 25,000.
Total Assets
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| GT Biopharma, Inc. Annual Total Assets (Millions of US $) | |
|---|---|
| 2020 | $6 |
| 2019 | $0 |
| 2017 | $254 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $1 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
GT Biopharma, Inc. Total Assets — FAQ
GT Biopharma, Inc. (GTBP) total assets over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GTBP's total assets history?
The chart and table above show GT Biopharma, Inc.'s total assets by year and by quarter, including the growth rate.